Tech Company Financing Transactions
Ascus Biosciences Funding Round
On 5/28/2020, Ascus Biosciences raised $46 million in Series B funding from Temasek Holdings, Anterra Capital and Cavallo Ventures.
Transaction Overview
Company Name
Announced On
5/28/2020
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to continue expanding its customer sales and servicing teams, advance new and existing products in its product pipeline and continue refining its core technology platform and intellectual property foundation.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6450 Lusk Blvd. E109 / 209
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
In 2015, Ascus Biosciences set out on a path of discovery. Harnessing new genomics based technologies, we began working on a new kind of science, with the goal of improving animal health and nutrition from the inside out. By understanding the natural processes already at work within the animal, we're creating a new category of all-natural endomicrobial products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Seely
Chief Operating Officer
Jimmy Owens
Chief Scientific Officer
Mallory Embree
Controller
Jeffrey Graham
General Manager
Alejandro Chavez
General Manager
Oscar Gonzalez
Browse more venture capital transactions:
Prev: 5/28/2020: SmartRent venture capital transaction
Next: 5/28/2020: Kentik venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs